EUCTR2005-000658-56-SE进行中（未招募）不适用
PEG-asparaginase during two treatment courses in the treatment of childhood acute lymphoblastic leukemia (Användande av PEG-asparaginase under två behandlingsomgångar vid behandling av akut lymfatisk leukemi hos barn)
Deparment of pediatrics, Skejby Hospital, Denmark0 个研究点目标入组 85 人开始时间: 2005年12月13日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ålder 1-14 år.
- •Nydiagnosticerad akut lymfatisk leukemi (ALL) behandlad enligt det Nordiska leukemiprotokollet för ALL med ogynnsamma riskfaktorer (NOPHO-ALL 2000).
- •Behandlas på barnonkologiskt center i Norden
- •Informerat samtycke givet och påskrivet av vårdnadshavare
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergi mot PEG-asparaginase.
- •Pancreatit akut eller tidigare genomgången.
研究者
相似试验
Unknown
4 期
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment CoursesAcute Lymphoblastic LeukemiaNCT00192673Nordic Society for Pediatric Hematology and Oncology85
已完成
不适用
A pilot study of L-asparaginase monotherapy for Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection)Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection)JPRN-UMIN000003498Tokyo Medical and Dental University School of Medicine, Department of Hematology5
已完成
不适用
Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study.acute lymphoblastic leukemia (ALL)JPRN-UMIN000040630Japan Children's Cancer Study Group(JCCG)110
已完成
3 期
ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG AsparaginaseAcute Lymphoblastic LeukemiaNCT00819351Rigshospitalet, Denmark650
已完成
1 期
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)Adult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaNCT00866307Children's Oncology Group104